<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02455817</url>
  </required_header>
  <id_info>
    <org_study_id>REWARDS- Angina</org_study_id>
    <nct_id>NCT02455817</nct_id>
  </id_info>
  <brief_title>REWARDS-Angina at Follow up Post Stenting</brief_title>
  <official_title>REWARDS-Angina at Follow up Post Stenting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medstar Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medstar Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single center, retrospective registry to collect data regarding the rate of angina (any and&#xD;
      CCS clas III/IV) within 12 months post stent implantation. In addition, the target vessel&#xD;
      revascularization rate within 12 months post stent implantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to retrospectively identify the rate of angina (any as well as&#xD;
      CCS class III/IV) up to one (1) year following stent implantation. The following drug eluting&#xD;
      stents will be evaluated in addition to bare metal stents; Cypher, Taxus Express, Xience V,&#xD;
      Resolute and Promus Element. The target vessel revascularization rate will also be compared&#xD;
      for the 6 stent types within one (1) year.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Angina</measure>
    <time_frame>up to 1 year</time_frame>
    <description>post PCI for a variety of DES and BMS</description>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Rate of Angina</condition>
  <arm_group>
    <arm_group_label>Cypher</arm_group_label>
    <description>Access rate of angina including degree, post PCI up to 1 year for the Cypher stent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Taxus Express</arm_group_label>
    <description>Access rate of angina including degree, post PCI up to 1 year for the Taxus Express stent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xience V</arm_group_label>
    <description>Access rate of angina including degree, post PCI up to 1 year for the Xience V stent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Promus Element</arm_group_label>
    <description>Access rate of angina including degree, post PCI up to 1 year for the Promus stent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resolute</arm_group_label>
    <description>Access rate of angina including degree, post PCI up to 1 year for the Resolute stent.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bare metal stents</arm_group_label>
    <description>Access rate of angina including degree, post PCI up to 1 year for bare metal stents.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients male or female, 18 years or older who have received at least one commercially&#xD;
        available Drug Eluting Stent or Bare Metal Stent: Cypher, Taxus Express, Xience V, Promus&#xD;
        Element, Resolute, or Bare Metal Stents&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients, male or female, &gt; 18 years of age,&#xD;
&#xD;
          -  Patients who received at least one (1) commercially available Drug Eluting Stent or&#xD;
             Bare Metal Stent: Cypher, Taxus Express, Xience V, Promus Element, Resolute, or Bare&#xD;
             Metal Stents&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Received more than one type of DES as listed above or both a BMS and DES (as listed&#xD;
             above)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 26, 2015</study_first_submitted>
  <study_first_submitted_qc>May 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2015</study_first_posted>
  <last_update_submitted>October 8, 2020</last_update_submitted>
  <last_update_submitted_qc>October 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

